Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Multiple Myeloma 4Vomiting 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Prostatic Neoplasms 1Postoperative Nausea and Vomiting 1Pain, Intractable 1Oropharyngeal Neoplasms 1Nausea 1Lymphoma, Non-Hodgkin 1Leukemia, Plasma Cell 1Immunoglobulin Light-chain Amyloidosis 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Cancer Pain 1Breast Neoplasms 1

Interventions

Cisplatin 6Radiotherapy 5Surveys and Questionnaires 4Paclitaxel 3Surgical Procedures, Operative 2Physical Examination 2Gemcitabine 2Drug Therapy 2Docetaxel 2Cetuximab 2Blood Specimen Collection 2pembrolizumab 1nimotuzumab 1fluoromisonidazole 1fludarabine 1durvalumab 1Rubidium-82 1Ropivacaine 1Ritonavir 1Nivolumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Lidocaine 1Interviews as Topic 1Indinavir 1Immunotherapy 1Fluorouracil 1Fluorodeoxyglucose F18 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oropharyngeal Neoplasms × Calcium Dobesilate × Clear all
NCT04085120 2019-09-11

Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer Pain

All India Institute of Medical Sciences

Phase NA Unknown
60 enrolled
Head & Neck

Cancer Pain, Oropharyngeal Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡